权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Heart Development and Disease: From Genes to Cures

心脏发育和疾病：从基因到治疗

基本信息

批准号：
10608624
负责人：
TERRY L. SHEPPARD
金额：
$ 1.62万
依托单位：
KEYSTONE SYMPOSIA
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-02-01 至 2024-01-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10608624
关键词：
Acceleration Address Adult Animal Disease Models Animal Model Biology Biophysics Cardiac Cardiac Myocytes Cardiovascular Diseases Cardiovascular system Cell Therapy Cell model Cells Child Clinical Trials Collaborations Development Developmental Biology Disadvantaged Disease Disease Progression Disease model Educational workshop Event Fertilization Functional disorder Genes Genetic Goals Health Expenditures Heart Heart Diseases Human Investigation Knowledge Lead Learning Mediator Medical Methodology Molecular Target Morbidity - disease rate New Mexico Onset of illness Operative Surgical Procedures Organ Outcome Pathogenesis Patients Population Process Research Research Personnel Scientist Signal Pathway Techniques Technology Therapeutic Agents Tissue Engineering Tissue Model Tissues Translating Translations Tungsten Vascular Diseases Work aging population cardiac repair cardiac tissue engineering cardiogenesis clinical application clinical practice congenital heart disorder design improved in vitro Model in vivo Model inherited cardiomyopathy innovation insight interest meetings mortality novel novel strategies novel therapeutics posters programs regenerative biology regenerative therapy stem cell model stem cells symposium therapeutic development therapy development tool translational therapeutics treatment strategy

项目摘要

ABSTRACT Support is requested for a Keystone Symposia conference entitled Heart Development and Disease: From Genes to Cures, organized by Drs. Sean Wu, Wolfram Zimmermann and Christine Seidman. The conference will be held in Santa Fe, New Mexico from February 12-15, 2023. Significant advances in recent years in mechanistic understanding of cardiac development, function, and degeneration have stimulated interest in identifying novel therapeutic agents that may help treat children and adult patients with cardiovascular diseases. However, therapies developed in cell and animal models rarely translate well to human patients. The goals of this conference are to advance our understanding of heart formation and homeostatic function and how derangement in these processes lead to diseases and organ dysfunction. Since human cardiovascular tissue is difficult to obtain for experimental perturbation this conference will address the use of a spectrum of cells and engineered tissue models as well as small and large animal models of disease. This conference will also feature the state-of-the art tools and technologies that have revolutionized the developments in various domains of cardiovascular research including heart developmental biology, genetics of cardiomyopathy and congenital heart disease, cardiac tissue engineering, and cell and regenerative therapy. This event will bring together scientists with diverse research backgrounds who employ different tools and technologies to address mechanisms of cardiomyocyte and vascular dysfunction and will uncover new approaches to cardiovascular biology. The program is designed to showcase innovative, molecularly targeted strategies to treat both rare and common cardiovascular diseases.

摘要